http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018212256-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4579923d27661dd10fea760553ccf784 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55d635e782a809567a34cd2f50bc440a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 |
| filingDate | 2018-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13ae85d7df48fe9a925eff2ca55f588a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf8a42969ef08c76b75c7f9257df51f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2b2c656ab2aba6b0f4e2fd933fc96fe |
| publicationDate | 2018-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2018212256-A1 |
| titleOfInvention | THERAPEUTIC AGENT USING ESTROGEN RECEPTOR β PARTIAL AGONIST HAVING ESTROGEN RECEPTOR α INHIBITING EFFECT, FOR PAIN AND/OR STRUCTURAL LESION FROM GYNECOLOGICAL DISORDER SUCH AS ENDOMETRIOSIS AND UTERUS ADENOMYOSIS |
| abstract | [Problem] To provide a pharmaceutical agent for treatment of pain associated with a gynecological disorder and/or treatment of a structural lesion caused by a gynecological disorder. [Solution] A therapeutic agent for pain associated with a gynecological disorder and/or a structural lesion caused by the gynecological disorder, the therapeutic agent containing an estrogen receptor α inhibiting β partial agonist represented by structural formula (a), a pharmaceutically acceptable salt thereof, or a hydrate thereof as an effective component. |
| priorityDate | 2017-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.